Astellas Pharma Inc. (TYO: 4503)

Astellas Pharma Revenue

Astellas Pharma had revenue of 462.50B JPY in the quarter ending September 30, 2024, with 17.94% growth. This brings the company's revenue in the last twelve months to 1.77T, up 16.32% year-over-year. In the fiscal year ending March 31, 2024, Astellas Pharma had annual revenue of 1.60T with 5.60% growth.

• Revenue (ttm): 1,772.16B
• Revenue Growth: +16.32%
• P/S Ratio: 1.69
• Revenue / Employee: 120.11M
• Employees: 14,754
• Market Cap: 2,990.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	1,603.67B	85.05B	5.60%
Mar 31, 2023	1,518.62B	222.46B	17.16%
Mar 31, 2022	1,296.16B	46.64B	3.73%
Mar 31, 2021	1,249.53B	-51.32B	-3.94%
Mar 31, 2020	1,300.84B	-5.51B	-0.42%